Abstract
AbstractSince the 1990s, insurance has been the primary field focused on the social disadvantages of using genetic test results because of the concerns related to adverse selection. Although life insurance is popular in Japan, Japan does not currently have any regulations on the use of genetic information and insurers have largely kept silent for decades. To reveal insurers’ attitudes on the topic, we conducted an anonymous questionnaire survey with 100 insurance company employees and recruited nine interviewees from the survey respondents. We found that genetic discrimination is not generally considered as a topic of human rights. We also found that insurers have uncertain fears and concerns about adverse selection in terms of actuarial fairness but not regarding profits. When it comes to preparing guidelines on the use of genetic information by Japanese insurers, we believe that public dialog and consultation are necessary to gain understanding of the people.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference20 articles.
1. Stewart AC. Ethical and social implications of the Human Genome Project: the issue in the UK. Sci Policy. 1991;18:123–9.
2. McGleenan T. Legal and policy issues in genetics and insurance. Community Genet. 2000;3:45–49.
3. Macdonald AS. Moratoria on the use of genetic tests and family history for mortgage-related life insurance. Br Actuarial J. 2003;45:347–412.
4. Viswanathan KS. Adverse selection in term life insurance purchasing due to the BRCA 1/2 genetic test and elastic demand. J Risk Insurance. 2007;74:65–98.
5. Deguchi H. The introduction to life insurance. Tokyo: Iwanami Shoten Publishers; 2009.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献